Innovative Systems to Deliver Allergen Powder for Epicutaneous Immunotherapy.

Front Immunol · 2021 · PMC8033039 · PMID 33841430

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

GFP + APCs migrate toward individual microchannel (red) composed of powdered OVA over time, becoming highly significant on day 2 (d2), peaking on day 3 (d3), and declining over 6 to 10 days until all powder is ingested ( Figure 2 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.